AD/PD 2021 | AD/PD 2021 highlights: immunotherapies, 3D cell models and copathologies

Tiago Outeiro, PhD, University Medical Center Göttingen, Göttingen, Germany, shares his highlights from the AD/PD™ 2021 conference, such as the presentation from Roger Nitsch on monoclonal antibodies targeting amyloid beta for the potential treatment of Alzheimer’s disease (AD) and Rudolph Tanzi’s talk on a three-dimensional neural cell culture model of AD. Dr Outeiro also describes other exciting talks on the complexity of AD and copathologies. This interview took place during the AD/PD™ 2021 conference.